Keyword: Bristol-Myers Squibb (BMS)
News
10.09.2015
- UK drug cost-effectiveness agency National Institute for Health and Care Excellence, NICE, has approved the use of US drugmaker Merck’s Keytruda for treatment of certain cases of...
News
03.09.2015
- Bristol-Myers Squibb (BMS) will pay as much as $1.25 billion for the worldwide rights to a developing fibrosis drug as part of a deal that also gives it the right to buy the...
News
27.07.2015
- The US Food and Drug Administration has designated the Bristol-Mayers Squibb experimental HIV drug BMS-663068 as a breakthrough treatment, which could accelerate its approval. The...
News
30.06.2015
- Amine Tahiri has joined the Development Services Sales team of Recipharm as sales director for France with effect from July 1, 2015. Tahiri has more than 16 years of experience in...
News
08.06.2015
- In a new international clinical trial, two cancer drugs developed by US drugmaker Bristol-Myers Squibb are reported to have shrunk tumors in nearly 60% of people with advanced...
News
27.02.2015
- The Bayer group is on track to become a pure life sciences group by mid-2016, by which time it intends to have carved out its plastics sub-group, CEO Marijn Dekkers said at the...
News
31.10.2014
- US drugmaker Bristol-Myers Squibb and Swiss fine and specialty chemicals specialist Lonza have announced a multi-year expansion of their existing biologics manufacturing agreement...
News
23.09.2014
- Bayer is said to have chosen investment bank Rothschild to advise on its plan for an initial public offering (ipo) of engineering plastics sub-group Bayer MaterialScience (BMS)...
